Liposarcoma is a rare type of cancer that begins in fat cells, most commonly appearing as slowly growing masses in the belly, arms, or legs. While these tumors can develop anywhere in the body where fat tissue exists, they often remain undetected for extended periods until they grow large enough to cause symptoms or be felt under the skin.

Understanding Liposarcoma: A Rare Cancer

Liposarcoma represents one of the most common types of soft tissue sarcoma, which are cancers that develop in the body’s connective tissues. Despite being labeled as “common” within this category, liposarcoma itself is quite rare. The disease affects approximately 1 in 100,000 people in the United States each year, while soft tissue sarcomas as a whole affect about 4 in 100,000 people annually.^[1][2]

What makes liposarcoma particularly challenging is that it does not develop from common fatty lumps called lipomas, which are completely benign and much more prevalent. Instead, liposarcoma arises from immature fat cells that develop abnormally into cancerous growth as a result of errors in their genes. This distinction is crucial because many people naturally develop lipomas throughout their lives without any risk of them becoming cancerous.^[4][14]

The disease typically appears in the deeper tissues of the body rather than just beneath the skin. Most liposarcomas form in the muscles of the limbs or in the abdomen, particularly in the area behind the abdominal cavity known as the retroperitoneum. This deep-seated nature of the tumors explains why they can grow quite large before being discovered.^[1][4]

Epidemiology: Who Gets Liposarcoma and How Often

Liposarcoma shows distinct patterns in who it affects. The disease primarily strikes older adults, with the average age at diagnosis being around 50 years, though cases can occur at any age. Most patients are diagnosed between the ages of 50 and 65, making this a cancer predominantly of middle age and later life. While rare, cases of liposarcoma in children have been documented, though when the disease does affect younger individuals, it typically occurs during adolescence.^[2][4][6]

Gender also plays a role in the distribution of this disease. Liposarcoma tends to affect men more frequently than women, with some studies reporting roughly double the number of male patients compared to female patients. However, this gender difference is not overwhelming, and women certainly remain at risk for developing the condition.^[5][2]

According to data from England, approximately 454 cases of liposarcoma are diagnosed every year, representing about 11.51% of all soft tissue sarcomas and roughly 0.15% of all cancers. The median age at diagnosis in this population is 65 years old. These statistics underscore both the rarity of the disease and its tendency to affect older populations.^[5]

Liposarcoma is recognized as the most common subtype of soft tissue sarcoma worldwide, accounting for less than 20% of all soft tissue sarcomas in the United States. However, this “common” designation is relative—within the already rare category of soft tissue sarcomas, liposarcoma is simply the most frequently occurring type. There is no significant association between liposarcoma and race, meaning people of all ethnic backgrounds face similar risks.^[4][11]

Causes: Why Liposarcoma Develops

The exact cause of liposarcoma remains unknown, which can be frustrating for patients seeking to understand why they developed this disease. Unlike some cancers that have clear links to lifestyle choices or environmental exposures, liposarcoma appears to develop without obvious triggers. Medical experts believe that the disease occurs when cells in the body undergo changes that cause them to grow and multiply out of control, forming a tumor. These abnormal cells originate from what are thought to be fat cell precursors—early-stage cells that would normally develop into mature fat tissue but instead become cancerous.^[1][4]

The American Cancer Society has identified several apparent risk factors for soft tissue sarcomas in general, though importantly, many patients diagnosed with liposarcoma have no apparent risk factors at all. This randomness can be difficult to accept, especially for individuals who have lived healthy lives. Some surgeons describe the development of liposarcoma as “bad luck”—emphasizing that there is no link to genetics or lifestyle in most cases, making it a random occurrence that could affect anyone.^[4]

Research continues into the specific genetic mutations that lead to liposarcoma, and scientists are making progress in understanding the molecular abnormalities present in different types of this cancer. This research offers hope for more targeted treatments in the future, but for now, the underlying cause of why these genetic errors occur remains largely a mystery.^[4][11]

Risk Factors: What Increases the Chance of Developing Liposarcoma

While the cause of liposarcoma is unknown, researchers have identified several factors that may increase a person’s risk of developing soft tissue sarcomas, including liposarcoma. Understanding these risk factors is important, though it’s equally important to remember that having risk factors does not mean someone will definitely develop the disease, and lacking risk factors doesn’t provide complete protection.^[4]

Exposure to radiation, particularly radiation therapy used to treat other types of cancer, has been identified as a potential risk factor. Patients who have undergone radiation treatment for one cancer may face a slightly elevated risk of developing a sarcoma years later in the area that was treated. This doesn’t mean radiation therapy should be avoided when needed, but it does highlight the importance of long-term monitoring for cancer survivors.^[4]

Certain inherited genetic conditions can predispose individuals to developing soft tissue sarcomas. These include neurofibromatosis, a condition that causes tumors to form on nerve tissue, and Li-Fraumeni syndrome, a rare disorder that greatly increases the risk of developing several types of cancer. People with these genetic syndromes often undergo more frequent screening to catch any cancers early.^[4]

Damage or trauma to the lymphatic system has also been linked to an increased risk of soft tissue sarcomas. The lymphatic system is a network of vessels and tissues that help rid the body of toxins and waste. When this system is damaged, either through surgery, radiation, or infection, it may create conditions that favor tumor development.^[4]

Exposure to certain toxic chemicals may play a role, though this connection to liposarcoma specifically is not entirely clear. Some chemical exposures have been linked to increased rates of soft tissue sarcomas in general, but establishing direct causation remains challenging. Age itself is also a significant risk factor, as liposarcoma predominantly affects people in their 50s and 60s.^[4]

Symptoms: How Liposarcoma Affects the Body

One of the challenging aspects of liposarcoma is that it often causes no symptoms in its early stages. The tumors typically grow slowly and silently, remaining undetected until they reach a size where they begin to affect surrounding tissues or become visible or palpable. This lack of early warning signs means that many liposarcomas are discovered incidentally during examinations or imaging tests for unrelated conditions, or they’re found only after they’ve grown quite large.^[1][2]

The symptoms that eventually develop depend heavily on where in the body the tumor is located. When liposarcoma forms in the arms or legs, the most common early sign is a growing lump or mass of tissue under the skin. This lump typically appears in the thighs or behind the knees, and it may initially be painless. As the tumor grows, it can cause pain if it begins to press on nearby nerves. The affected limb may also experience swelling, and some patients notice weakness in the limb as the tumor interferes with normal muscle function.^[1][6]

Liposarcomas that develop in the abdomen present a different set of challenges. Because the abdominal cavity has considerable space, these tumors can grow to substantial sizes before causing any symptoms at all. When symptoms do appear, they may include abdominal pain or a sensation of abdominal swelling. Patients often report feeling full sooner than usual when eating, as the tumor takes up space in the abdomen and presses against the stomach. Constipation can occur if the tumor presses on the intestines, interfering with normal bowel function.^[1][6]

More concerning symptoms of abdominal liposarcoma can include blood in the stool, which may appear bright red or cause the stool to look black and tarry. Some patients experience bloody vomit or nausea. Unintended weight loss may occur, and some individuals develop general symptoms like fevers, chills, fatigue, or night sweats—though these non-specific symptoms can be associated with many conditions.^[6]

Liposarcomas in other locations can cause symptoms specific to those areas. For example, a tumor in the lungs may make breathing difficult, while a tumor pressing on other organs can interfere with those organs’ normal functions. Because most liposarcomas grow very slowly and rarely cause pain initially, patients may not notice any changes in their body unless they observe a large bump that doesn’t go away or continues to grow larger over time.^[2]

Prevention: Can Liposarcoma Be Prevented?

Unfortunately, because the exact cause of liposarcoma is unknown and the disease often appears to develop randomly without clear risk factors, there are no proven strategies for preventing it. This can be particularly difficult for people who are health-conscious and take active steps to prevent disease. Unlike some cancers where lifestyle modifications such as not smoking, maintaining a healthy diet, exercising regularly, or limiting alcohol consumption can reduce risk, liposarcoma does not show strong associations with any particular behaviors or habits that could be modified.^[4]

For individuals with known genetic syndromes that increase the risk of soft tissue sarcomas, such as neurofibromatosis or Li-Fraumeni syndrome, preventive strategies focus on enhanced surveillance rather than prevention per se. These patients may undergo more frequent physical examinations and imaging tests to detect any tumors at the earliest possible stage, when they are most treatable. Genetic counseling can also be valuable for families affected by these conditions.^[4]

People who have undergone radiation therapy for other cancers should maintain regular follow-up appointments with their healthcare providers. While the risk of developing a secondary cancer like liposarcoma from radiation exposure is relatively small, monitoring allows for early detection if any problems do arise. Similarly, individuals who have been exposed to certain toxic chemicals through their work or environment should discuss appropriate screening with their healthcare providers.^[4]

The most important preventive measure anyone can take is to pay attention to their body and seek medical evaluation for any unusual lumps, persistent swelling, or symptoms that don’t resolve. While most lumps are benign, any new mass that appears, particularly if it’s growing, painless, and located deep in the tissues, should be evaluated by a healthcare professional. Early detection, while not prevention, offers the best chance for successful treatment outcomes.^[1]

Pathophysiology: How Liposarcoma Changes Normal Body Function

Understanding the pathophysiology of liposarcoma—meaning how the disease alters normal bodily functions—helps explain why symptoms occur and how treatments work. Liposarcoma begins when fat cell precursors undergo genetic mutations that cause them to lose their normal growth control mechanisms. These cells then multiply uncontrollably, forming a mass of abnormal tissue. Unlike normal fat tissue, which serves important functions in energy storage, insulation, and hormone production, liposarcoma tissue serves no useful purpose and instead disrupts normal body function.^[11]

There are several subtypes of liposarcoma, classified based on how the cancer cells appear under a microscope and their molecular characteristics. These subtypes have important implications for how aggressive the cancer is and how it should be treated. Well-differentiated liposarcoma, the most common type, accounts for 30% to 50% of all cases. These tumors look very similar to normal fat tissue when examined under a microscope, grow slowly, and are generally not life-threatening. When well-differentiated liposarcoma occurs in the arms or legs, it’s sometimes called an atypical lipomatous tumor. In the retroperitoneum, however, the same type of tumor is called well-differentiated liposarcoma because of its higher tendency to recur in that location.^[2][5]

Dedifferentiated liposarcoma can develop from well-differentiated liposarcoma, representing a progression to a more aggressive form. Unlike its predecessor, dedifferentiated liposarcoma typically grows quickly and behaves more aggressively, with a higher likelihood of spreading to other parts of the body. This type accounts for a significant portion of liposarcomas, particularly those found in the retroperitoneum.^[2][4]

Myxoid liposarcoma and round cell liposarcoma together represent about 30% of all liposarcomas, making them the second most common category. Myxoid liposarcoma differs from other types in that it tends to affect younger adults, typically between ages 35 and 55. These tumors usually develop in the legs and have a particular tendency to spread to unusual locations, including bones (such as the pelvic bones or spine) and organs like the heart, lungs, or esophagus. The term “round cell” describes how the cancer cells appear under the microscope, and round cell liposarcomas are generally more aggressive than pure myxoid types.^[2][4]

Pleomorphic liposarcoma is the rarest subtype but also the most aggressive. These tumors can grow very rapidly and spread quickly from their original location to other areas of the body through a process called metastasis. When cancer spreads, it typically travels through the bloodstream or lymphatic system to establish new tumors in distant organs, most commonly the lungs.^[2]

The mechanical effects of liposarcoma on the body depend primarily on the tumor’s size and location. As the tumor grows, it occupies space and compresses surrounding structures. In the limbs, this compression can press on nerves causing pain, interfere with blood vessels affecting circulation, or push against muscles limiting mobility and strength. In the abdomen, growing tumors can compress the intestines causing digestive problems, press on the kidneys affecting their function, or push against the stomach causing early satiety and weight loss.^[2]

Biochemically, liposarcoma cells have alterations in their normal metabolic processes. Research has revealed specific molecular abnormalities in different liposarcoma subtypes. For instance, well-differentiated and dedifferentiated liposarcomas often have amplification of a particular chromosomal region, while myxoid liposarcomas typically have a characteristic chromosomal translocation. These genetic signatures not only help pathologists accurately diagnose the subtype but also provide potential targets for new treatments. Understanding these molecular abnormalities has opened doors to developing therapies that specifically target the cancer cells while sparing normal tissues.^[11]

The local recurrence rate of liposarcoma—meaning the cancer coming back in the same area after treatment—varies by subtype and location. Well-differentiated liposarcomas, particularly those in the retroperitoneum, have a high local recurrence rate that can reach 10% or higher, with recurrences possible even up to 25 years after the original surgery. This long-term risk necessitates lifelong follow-up for many patients. More aggressive subtypes may recur more quickly and also have higher rates of distant metastasis, where the cancer spreads to other organs.^[4]